HAVCR2 and neoplasm: Ex vivo flow cytometry showed increased TIM3 expression on tumor-infiltrating immune cells (TICs) in both myeloid and lymphoid compartments compared with matched PBMCs and healthy control PBMCs (Figure 4B).